Knowledge Hub
Coronavirus
A trusted source for the latest science on SARS-CoV-2 and COVID-19
A global challenge like the current COVID-19 pandemic can only be defeated when research results are rapidly and openly shared and all stakeholders work together – scientists, health workers, publishers, funders, policymakers, and government officials.
The Frontiers Coronavirus Knowledge Hub provides an up-to-date source of trusted information and analysis on COVID-19 and coronaviruses, including the latest research articles, information, and commentary from our world-class scientific community.
As we pull together as a community – calmly, responsibly, and resolutely – during the COVID-19 outbreak, we are keen to hear from you. Please do not hesitate to send your ideas for new research directions, stakeholder engagement and initiatives around coronavirus and the current global health crisis. »Send your ideas
Frontiers collaborations
World Economic Forum COVID Action Platform
Broad coalition of public, private, and civil society sectors worldwide, working to protect lives and livelihoods
Wellcome Trust Statement
Commitment from researchers, journals and funders on sharing research data and findings relevant to the novel coronavirus (COVID-19) outbreak
International Union of Immunological Societies
Umbrella organization for many of the regional and national societies of immunology throughout the world
Research Topics
COVID-19 & SOCIETY
Impact on ethnic & racial minorities
From over-representation in infection, prognosis and mortality rates, to the disproportionate impact of social distancing on mental health and wellbeing, how and why has the COVID-19 pandemic affected minority groups?
COVID-19 & SOCIETY
Death, mourning and COVID-19
How can we learn to grieve effectively as we mourn our loved ones and ways of life lost to COVID-19? Hear more from editor Lydia Gimenez-Llort, and submit your research on mourning during the pandemic. »Participate now
COVID-19 TREATMENT
Repurposing drugs to fight COVID-19
Many existing approved drugs are being rapidly trialled by researchers as potential viable treatments for COVID-19 symptoms. Share your work on the roles and regulatory challenges of repurposed drugs. »Participate now
COVID-19 & SOCIETY
Impacts on education leadership
Education systems have faced huge challenges during the pandemic, as they navigate regularly changing information, resources and policies. What lessons have we learned from their leaders and leadership? »Participate now
Coronavirus Research & Funding Resources
FOR RESEARCHERS
Open funding calls
Browse our curated list of open funding calls and other support for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research.
FOR FUNDERS
Expert grant reviewers
Use our AI-powered tool to identify experts for fast track peer-reviewing of COVID-19 research proposals, based on the same technology as the Frontiers Open Science platform.
FOR RESEARCHERS
Public health data
Access aggregated and non-aggregated data sets on COVID-19 symptoms and spread, available publicly or on request to eligible researchers and health authorities.
Expert Commentary
COVID-19 & SOCIETY
Managing surgical patients during COVID-19
6 August 2020 | Performing surgery during a global pandemic requires a very different approach to patient management: we need to learn quickly to prepare hospitals and patients for a second wave, explains general and liver transplant surgeon Francesco Giovinazzo of the Fondazione Policlinico Universitario A Gemelli IRCCS in Rome, and Specialty Chief Editor of Frontiers in Oncology.
COVID-19 & SOCIETY
COVID-19: How have we coped?
8 July 2020 | What lessons have we learned about coping in a global pandemic? Prof Elliot Berry, of the Hebrew University Hadassah Medical School, on coping strategies developed during the pandemic - many of which may be here to stay.
COVID-19 DIAGNOSIS
CoughVid: A digital diagnosis tool
17 June 2020 | Can COVID-19 be diagnosed by artificial intelligence? Prof David Atienza Alonso on leveraging signal processing, pervasive computing and machine learning to enable at-home digital screening for COVID-19.
COVID-19 EPIDEMIOLOGY
Citizen science reveals symptoms
2 June 2020 | How data shared by 3 million participants through the COVID-19 Symptom Study has highlighted new symptoms including loss of taste and smell, with Dr Claire J Steves from King's College London.
IUIS Webinars
COVID-19 PATHOGENESIS
Longitudinal immune profiling
31 July 2020 | Elizabeth Mann and Madhvi Menon will discuss findings from their recent longitudinal immune profiling study, including key immune signatures that track with disease severity and can potentially be used to identify patients upon admission that are destined for intensive care, during a webinar on 31 July 2020 at 16:00 CEST.
COVID-19 IMMUNOLOGY
Evaluating anti-SARS-CoV-2 immunity
20 July 2020 | Using Ramos B cells where the B cell antigen receptor is replaced by the spike protein of SARS-CoV-2, Michael Reth and his team are investigating spike-specific antibody responses and monoclonal antibodies by flow cytometry.
COVID-19 IMMUNOLOGY
Early warning for severe cases
13 July 2020 | Prof Adrian Hayday, Professor of Immunobiology at King’s College London, describes new research on the immune response revealing possible early warning signs for severe COVID-19 symptoms. »Watch a summary
COVID-19 EPIDEMIOLOGY
COVID-19 in South Africa
24 June 2020 | Prof Salim Abdool Karim, Director of the Centre for the AIDS Program of Research in South Africa, outlines the challenges facing the country as it emerges from an unsustainable lockdown. »Watch a summary
Top COVID-19 Research
RESEARCH TOPIC
Nanotechnology and Nanoscience to manage SARS-CoV-2 Variants of Concern
The impact of COVID-19, the infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is ongoing. In the wake of the Delta and Omicron variants – at the time of writing, April 2022, the most impactful and fastest spreading Variants of Concern (VOCs) - it is increasingly apparent that the scientific community must continue striving to mitigate the many clinical and public health management challenges arising from the pandemic. »Read more
VACCINE DEVELOPMENT
The 2021 R&D landscape for COVID-19 vaccines
02 August 2021 | COVID-19 has changed the landscape of vaccine development: what progress has been done in vaccine delivery? Share your work on COVID-19-related vaccine delivery, mode of action, adjuvants, administration routes, safety, pharmacokinetics and -dynamics, and the technology of COVID-19 vaccines to this new Research Topic at Frontiers. »Read more
MEDICAL TECHNOLOGY
Computational approaches to innovate treatment and diagnosis of infectious diseases
16 October 2020 | This article collection explores computational approaches applied to the study of infectious diseases, including COVID-19. These methods are creating a new research field that takes advantage of the great progress from molecular and structural biology, immunology, bioinformatics and related areas to foster the understanding of infectious diseases and drive innovation in treatment and diagnosis. »Participate now
COVID-19 WOMEN’S HEALTH
Depression and anxiety rise among new moms amidst the COVID-19 pandemic
30 June 2020 | Pregnant and postpartum women are already at a high risk of depression and anxiety. The coronavirus pandemic is exacerbating those struggles according to a recent study published in Frontiers in Global Women’s Health, which found that the likelihood of maternal depression and anxiety has substantially increased during the health crisis. »See article
Resources for Children
FRONTIERS FOR YOUNG MINDS
What is COVID-19?
20 May 2020 | A summary of what we know about SARS-CoV-2 so far and how to stay safe from COVID-19, written by scientists and reviewed by kids.
Other Resources
WORLD ECONOMIC FORUM
COVID-19 Transformation Map
Publications, videos and data on the impacts of, and responses to, the coronavirus pandemic, from the World Economic Forum’s Strategic Intelligence Unit.
DIMENSIONS
SARS-CoV-2 & COVID-19 resources
List of 2020 publications, clinical trials, policy documents, grants, and patents on Dimensions, a research insights platform. »Explore
JOHNS HOPKINS UNIVERSITY & MEDICINE
Live COVID-19 updates
Continually updated interactive map highlighting confirmed cases, fatalities, and recoveries associated with COVID-19. »Explore